BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19033784)

  • 21. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of chest radiography in the diagnosis and follow-up of pulmonary metastasis in differentiated thyroid cancer.
    Somboonporn C; Simthamnimit P; Puttharak W; Tumsatan P; Ngamjarus C; Roysri K
    J Med Assoc Thai; 2010 Mar; 93 Suppl 3():S52-60. PubMed ID: 21299092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
    Hindié E; Mellière D; Lange F; Hallaj I; de Labriolle-Vaylet C; Jeanguillaume C; Lange J; Perlemuter L; Askienazy S
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):974-81. PubMed ID: 12734689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
    Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
    Qiu ZL; Shen CT; Luo QY
    Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning.
    Alzahrani AS; Bakheet S; Al Mandil M; Al-Hajjaj A; Almahfouz A; Al Haj A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5294-300. PubMed ID: 11701695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chest computed tomography (CT) in patients with micronodular lung metastases of differentiated thyroid carcinoma.
    Piekarski JD; Schlumberger M; Leclere J; Couanet D; Masselot J; Parmentier C
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):1023-7. PubMed ID: 3988552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of 18F-FDG PET/CT in patients with TENIS syndrome: correlation with thyroglobulin levels.
    Özdemir E; Yildirim Poyraz N; Polat SB; Turkolmez S; Ersoy R; Cakir B
    Ann Nucl Med; 2014 Apr; 28(3):241-7. PubMed ID: 24379008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer.
    Ha S; Oh SW; Kim YK; Koo do H; Jung YH; Yi KH; Chung JK
    J Korean Med Sci; 2015 Jul; 30(7):876-81. PubMed ID: 26130949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinoma.
    Song HJ; Wu CG; Xue YL; Xu YH; Qiu ZL; Luo QY
    Clin Nucl Med; 2012 Jun; 37(6):e129-33. PubMed ID: 22614210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential follow-up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis.
    Huang SH; Wang PW; Huang YE; Chou FF; Liu RT; Tung SC; Chen JF; Kuo MC; Hsieh JR; Hsieh HH
    Thyroid; 2006 Dec; 16(12):1273-8. PubMed ID: 17199438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer.
    Lim I; Kim SK; Hwang SS; Kim SW; Chung KW; Kang HS; Lee ES
    Ann Nucl Med; 2012 Dec; 26(10):777-86. PubMed ID: 22869417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.